| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.22e-05 | 14 | 68 | 3 | GO:2001046 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | IL12B THBS1 ABI1 ABI3 PTPRC ABI2 PIK3R1 TBK1 RGPD1 PFKFB1 PIBF1 NOS1 | 2.68e-05 | 879 | 68 | 12 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | IL12B THBS1 ABI1 ABI3 PTPRC ABI2 PIK3R1 TBK1 RGPD1 PFKFB1 PIBF1 NOS1 | 2.68e-05 | 879 | 68 | 12 | GO:0010562 |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | IL12B THBS1 ABI1 ABI3 PTPRC WARS1 ABI2 PIK3R1 TBK1 RGPD1 IMPACT PIBF1 NOS1 MEN1 | 3.82e-05 | 1226 | 68 | 14 | GO:0042325 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-tyrosine phosphorylation | 4.20e-05 | 193 | 68 | 6 | GO:0050731 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 4.45e-05 | 195 | 68 | 6 | GO:0006606 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | IL12B FLNA THBS1 PTPRC GIMAP5 ZC3H8 PIK3R1 HSPH1 LAMA2 PTPN23 LOXL3 MEN1 | 4.51e-05 | 927 | 68 | 12 | GO:0030155 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | IL12B THBS1 ABI1 ABI3 PTPRC ABI2 PIK3R1 TBK1 RGPD1 PIBF1 NOS1 | 4.52e-05 | 780 | 68 | 11 | GO:0042327 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | IL12B THBS1 ABI1 ABI3 PTPRC WARS1 ABI2 PIK3R1 TBK1 RGPD1 IMPACT PFKFB1 PIBF1 NOS1 MEN1 | 4.78e-05 | 1421 | 68 | 15 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | IL12B THBS1 ABI1 ABI3 PTPRC WARS1 ABI2 PIK3R1 TBK1 RGPD1 IMPACT PFKFB1 PIBF1 NOS1 MEN1 | 4.85e-05 | 1423 | 68 | 15 | GO:0051174 |
| GeneOntologyBiologicalProcess | import into nucleus | 5.26e-05 | 201 | 68 | 6 | GO:0051170 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 5.45e-05 | 405 | 68 | 8 | GO:0033674 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 5.79e-05 | 23 | 68 | 3 | GO:2001044 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | IL12B THBS1 ABI1 ABI3 PTPRC WARS1 ABI2 PIK3R1 TBK1 IMPACT PIBF1 NOS1 MEN1 | 7.21e-05 | 1133 | 68 | 13 | GO:0001932 |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 7.90e-05 | 686 | 68 | 10 | GO:0043549 | |
| GeneOntologyBiologicalProcess | regulation of protein tyrosine kinase activity | 7.95e-05 | 69 | 68 | 4 | GO:0061097 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell activation | 1.03e-04 | 141 | 68 | 5 | GO:0046634 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell activation | 1.03e-04 | 227 | 68 | 6 | GO:0046631 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | 1.23e-04 | 724 | 68 | 10 | GO:0001934 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 1.52e-04 | 350 | 68 | 7 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | 1.72e-04 | 611 | 68 | 9 | GO:0045859 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 1.91e-04 | 161 | 68 | 5 | GO:0051592 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 2.03e-04 | 490 | 68 | 8 | GO:0051347 | |
| GeneOntologyBiologicalProcess | positive regulation of protein tyrosine kinase activity | 2.08e-04 | 35 | 68 | 3 | GO:0061098 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell activation | 2.14e-04 | 89 | 68 | 4 | GO:0046635 | |
| GeneOntologyBiologicalProcess | response to topologically incorrect protein | 2.20e-04 | 166 | 68 | 5 | GO:0035966 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | IL12B THBS1 ABI1 ABI3 PTPRC MYCBP2 ABI2 PIK3R1 TBK1 PIBF1 NOS1 | 2.29e-04 | 937 | 68 | 11 | GO:0031401 |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 2.32e-04 | 375 | 68 | 7 | GO:0007162 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | IL12B THBS1 LARP4B ABI1 ABI3 PTPRC MYCBP2 ABI2 PIK3R1 TBK1 PIBF1 NOS1 METTL14 MEN1 | 2.42e-04 | 1458 | 68 | 14 | GO:0051247 |
| GeneOntologyBiologicalProcess | neuron development | FLNA MYO3A ABI1 ABI3 CPNE9 DST MYCBP2 ABI2 IMPACT LAMA2 SPG11 ATP9A MFRP NR2F1 | 2.51e-04 | 1463 | 68 | 14 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | FLNA MYO3A ABI1 ABI3 CPNE9 DST MYCBP2 ABI2 IMPACT LAMA2 SPG11 ATP9A NR2F1 | 2.53e-04 | 1285 | 68 | 13 | GO:0031175 |
| GeneOntologyBiologicalProcess | T cell differentiation | 2.60e-04 | 382 | 68 | 7 | GO:0030217 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-tyrosine phosphorylation | 2.75e-04 | 272 | 68 | 6 | GO:0050730 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 2.82e-04 | 802 | 68 | 10 | GO:0048812 | |
| GeneOntologyBiologicalProcess | regulation of membrane repolarization during cardiac muscle cell action potential | 2.96e-04 | 8 | 68 | 2 | GO:1905031 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | IL12B THBS1 ABI1 ABI3 PTPRC WARS1 MYCBP2 ABI2 PIK3R1 TBK1 IMPACT PIBF1 NOS1 MEN1 | 2.99e-04 | 1488 | 68 | 14 | GO:0031399 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | 3.05e-04 | 810 | 68 | 10 | GO:0051338 | |
| GeneOntologyBiologicalProcess | lamellipodium organization | 3.21e-04 | 99 | 68 | 4 | GO:0097581 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | IL12B MYO3A ABI1 ABI3 PTPRC ABI2 TBK1 RGPD1 LOXL3 PIBF1 NOS1 | 3.25e-04 | 976 | 68 | 11 | GO:0018193 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 3.33e-04 | 819 | 68 | 10 | GO:0120039 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | 3.40e-04 | 670 | 68 | 9 | GO:0120031 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 3.56e-04 | 826 | 68 | 10 | GO:0048858 | |
| GeneOntologyBiologicalProcess | positive regulation of humoral immune response mediated by circulating immunoglobulin | 3.80e-04 | 9 | 68 | 2 | GO:0002925 | |
| GeneOntologyBiologicalProcess | cell projection assembly | 3.99e-04 | 685 | 68 | 9 | GO:0030031 | |
| GeneOntologyBiologicalProcess | regulation of lamellipodium assembly | 4.40e-04 | 45 | 68 | 3 | GO:0010591 | |
| GeneOntologyBiologicalProcess | positive regulation of NK T cell activation | 4.74e-04 | 10 | 68 | 2 | GO:0051135 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | FLNA MYO3A ABI1 ABI3 CPNE9 DST MYCBP2 ABI2 IMPACT LAMA2 SPG11 ATP9A | 4.79e-04 | 1194 | 68 | 12 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of membrane repolarization during action potential | 5.78e-04 | 11 | 68 | 2 | GO:0098903 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell lineage commitment | 5.78e-04 | 11 | 68 | 2 | GO:2000328 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 6.18e-04 | 579 | 68 | 8 | GO:0045785 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 6.25e-04 | 580 | 68 | 8 | GO:0022407 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation | 6.45e-04 | 119 | 68 | 4 | GO:0043367 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell differentiation | 6.92e-04 | 12 | 68 | 2 | GO:0045588 | |
| GeneOntologyBiologicalProcess | regulation of NK T cell activation | 6.92e-04 | 12 | 68 | 2 | GO:0051133 | |
| GeneOntologyBiologicalProcess | positive T cell selection | 7.14e-04 | 53 | 68 | 3 | GO:0043368 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 7.27e-04 | 327 | 68 | 6 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 7.50e-04 | 329 | 68 | 6 | GO:0018212 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 7.53e-04 | 124 | 68 | 4 | GO:0007229 | |
| GeneOntologyBiologicalProcess | neuron migration | 7.65e-04 | 218 | 68 | 5 | GO:0001764 | |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | FLNA THBS1 PTPRC WARS1 MYCBP2 PIK3R1 IMPACT PIBF1 NOS1 CNOT1 MEN1 | 8.07e-04 | 1088 | 68 | 11 | GO:0051248 |
| GeneOntologyBiologicalProcess | regulation of cell activation | 8.10e-04 | 756 | 68 | 9 | GO:0050865 | |
| GeneOntologyBiologicalProcess | regulation of lamellipodium organization | 8.83e-04 | 57 | 68 | 3 | GO:1902743 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 8.99e-04 | 226 | 68 | 5 | GO:0045580 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell activation | 9.50e-04 | 14 | 68 | 2 | GO:0046645 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor production | 9.78e-04 | 133 | 68 | 4 | GO:0032760 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphate metabolic process | 9.84e-04 | 478 | 68 | 7 | GO:0045936 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorus metabolic process | 1.01e-03 | 480 | 68 | 7 | GO:0010563 | |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | 1.08e-03 | 631 | 68 | 8 | GO:0002683 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 1.08e-03 | 486 | 68 | 7 | GO:0007159 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor superfamily cytokine production | 1.09e-03 | 137 | 68 | 4 | GO:1903557 | |
| GeneOntologyBiologicalProcess | activation of Janus kinase activity | 1.09e-03 | 15 | 68 | 2 | GO:0042976 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell differentiation | 1.09e-03 | 15 | 68 | 2 | GO:0045586 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 1.13e-03 | 62 | 68 | 3 | GO:0002455 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 1.17e-03 | 240 | 68 | 5 | GO:0002695 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 1.18e-03 | 640 | 68 | 8 | GO:1903131 | |
| GeneOntologyBiologicalProcess | positive regulation of extrinsic apoptotic signaling pathway | 1.18e-03 | 63 | 68 | 3 | GO:2001238 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 1.23e-03 | 362 | 68 | 6 | GO:0034504 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 1.25e-03 | 142 | 68 | 4 | GO:0046683 | |
| GeneOntologyBiologicalProcess | cell junction organization | 1.27e-03 | 974 | 68 | 10 | GO:0034330 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell activation | 1.41e-03 | 17 | 68 | 2 | GO:0046643 | |
| GeneOntologyBiologicalProcess | response to unfolded protein | 1.45e-03 | 148 | 68 | 4 | GO:0006986 | |
| GeneOntologyBiologicalProcess | cell activation | IL12B FLNA THBS1 PTPRC GIMAP5 ZC3H8 PIK3R1 HSPH1 LOXL3 LTBR PIBF1 MEN1 | 1.46e-03 | 1356 | 68 | 12 | GO:0001775 |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | 1.47e-03 | 375 | 68 | 6 | GO:0001933 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | 1.51e-03 | 515 | 68 | 7 | GO:0072594 | |
| GeneOntologyBiologicalProcess | nuclear transport | 1.53e-03 | 378 | 68 | 6 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 1.53e-03 | 378 | 68 | 6 | GO:0006913 | |
| GeneOntologyBiologicalProcess | T cell selection | 1.54e-03 | 69 | 68 | 3 | GO:0045058 | |
| GeneOntologyBiologicalProcess | NK T cell activation | 1.58e-03 | 18 | 68 | 2 | GO:0051132 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 1.59e-03 | 381 | 68 | 6 | GO:0048545 | |
| GeneOntologyBiologicalProcess | negative regulation of blood pressure | 1.60e-03 | 70 | 68 | 3 | GO:0045776 | |
| GeneOntologyBiologicalProcess | leukocyte activation | IL12B THBS1 PTPRC GIMAP5 ZC3H8 PIK3R1 HSPH1 LOXL3 LTBR PIBF1 MEN1 | 1.62e-03 | 1186 | 68 | 11 | GO:0045321 |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell activation | 1.64e-03 | 153 | 68 | 4 | GO:0035710 | |
| GeneOntologyBiologicalProcess | extrinsic apoptotic signaling pathway | 1.64e-03 | 259 | 68 | 5 | GO:0097191 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.67e-03 | 71 | 68 | 3 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-12 production | 1.67e-03 | 71 | 68 | 3 | GO:0032655 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 1.79e-03 | 264 | 68 | 5 | GO:0050866 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell differentiation | 1.80e-03 | 157 | 68 | 4 | GO:0046632 | |
| GeneOntologyBiologicalProcess | interleukin-12 production | 1.81e-03 | 73 | 68 | 3 | GO:0032615 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell differentiation | 1.81e-03 | 73 | 68 | 3 | GO:0043370 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.85e-03 | 266 | 68 | 5 | GO:0045619 | |
| GeneOntologyCellularComponent | SCAR complex | 7.74e-06 | 12 | 70 | 3 | GO:0031209 | |
| GeneOntologyCellularComponent | filopodium tip | 3.94e-05 | 20 | 70 | 3 | GO:0032433 | |
| MousePheno | abnormal NK T cell morphology | 4.62e-06 | 107 | 57 | 6 | MP:0008036 | |
| MousePheno | abnormal NK T cell number | 4.62e-06 | 107 | 57 | 6 | MP:0008038 | |
| MousePheno | decreased NK T cell number | 1.22e-05 | 74 | 57 | 5 | MP:0008040 | |
| MousePheno | increased skeletal muscle cell glucose uptake | 1.38e-05 | 12 | 57 | 3 | MP:0031619 | |
| MousePheno | hypoglycemia | 7.97e-05 | 109 | 57 | 5 | MP:0000189 | |
| MousePheno | decreased circulating glucose level | TXNIP PHKB ARV1 PIK3R1 IMPACT SCUBE3 ABCC9 MFRP NT5DC3 MIER1 MEN1 | 9.14e-05 | 691 | 57 | 11 | MP:0005560 |
| MousePheno | increased insulin sensitivity | 1.12e-04 | 188 | 57 | 6 | MP:0002891 | |
| MousePheno | abnormal liver morphology | TXNIP PHKB FLNA THBS1 WARS1 ARV1 GIMAP5 ZC3H8 PIK3R1 TBK1 RGPD1 TMEM63C MFRP NOS1 PCTP MEN1 | 1.34e-04 | 1433 | 57 | 16 | MP:0000598 |
| MousePheno | abnormal esophagus morphology | 1.48e-04 | 66 | 57 | 4 | MP:0000467 | |
| MousePheno | abnormal effector T cell number | 1.71e-04 | 203 | 57 | 6 | MP:0013762 | |
| MousePheno | abnormal hepatobiliary system morphology | TXNIP PHKB FLNA THBS1 WARS1 ARV1 GIMAP5 ZC3H8 PIK3R1 TBK1 RGPD1 TMEM63C MFRP NOS1 PCTP MEN1 | 1.90e-04 | 1476 | 57 | 16 | MP:0002138 |
| MousePheno | increased muscle cell glucose uptake | 2.18e-04 | 29 | 57 | 3 | MP:0030021 | |
| MousePheno | liver degeneration | 2.66e-04 | 31 | 57 | 3 | MP:0003103 | |
| Domain | Abl-interactor_HHR_dom | 4.83e-08 | 3 | 69 | 3 | IPR012849 | |
| Domain | Abi_HHR | 4.83e-08 | 3 | 69 | 3 | PF07815 | |
| Domain | ABI | 1.35e-05 | 2 | 69 | 2 | IPR028457 | |
| Domain | SH3_1 | 3.51e-04 | 164 | 69 | 5 | PF00018 | |
| Domain | Copine | 4.76e-04 | 9 | 69 | 2 | PF07002 | |
| Domain | Copine | 4.76e-04 | 9 | 69 | 2 | IPR010734 | |
| Domain | Filamin | 7.24e-04 | 11 | 69 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 7.24e-04 | 11 | 69 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 7.24e-04 | 11 | 69 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 7.24e-04 | 11 | 69 | 2 | IPR017868 | |
| Domain | - | 8.67e-04 | 12 | 69 | 2 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 8.67e-04 | 12 | 69 | 2 | IPR029047 | |
| Domain | - | 1.02e-03 | 13 | 69 | 2 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.02e-03 | 13 | 69 | 2 | IPR018181 | |
| Domain | HSP70_C | 1.02e-03 | 13 | 69 | 2 | IPR029048 | |
| Domain | SH3 | 1.22e-03 | 216 | 69 | 5 | PS50002 | |
| Domain | SH3_domain | 1.32e-03 | 220 | 69 | 5 | IPR001452 | |
| Domain | HSP70 | 1.56e-03 | 16 | 69 | 2 | PF00012 | |
| Domain | HSP70_2 | 1.76e-03 | 17 | 69 | 2 | PS00329 | |
| Domain | HSP70_3 | 1.76e-03 | 17 | 69 | 2 | PS01036 | |
| Domain | HSP70_1 | 1.76e-03 | 17 | 69 | 2 | PS00297 | |
| Domain | Hsp_70_fam | 1.98e-03 | 18 | 69 | 2 | IPR013126 | |
| Domain | SRCR | 2.70e-03 | 21 | 69 | 2 | PF00530 | |
| Domain | Actinin_actin-bd_CS | 3.24e-03 | 23 | 69 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 3.24e-03 | 23 | 69 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.24e-03 | 23 | 69 | 2 | PS00019 | |
| Domain | SR | 3.82e-03 | 25 | 69 | 2 | SM00202 | |
| Domain | - | 3.82e-03 | 25 | 69 | 2 | 3.10.250.10 | |
| Domain | SRCR_1 | 4.13e-03 | 26 | 69 | 2 | PS00420 | |
| Domain | SRCR_2 | 4.13e-03 | 26 | 69 | 2 | PS50287 | |
| Domain | T_SNARE | 4.13e-03 | 26 | 69 | 2 | PS50192 | |
| Domain | SRCR-like_dom | 4.13e-03 | 26 | 69 | 2 | IPR017448 | |
| Domain | SRCR | 4.45e-03 | 27 | 69 | 2 | IPR001190 | |
| Domain | T_SNARE_dom | 5.12e-03 | 29 | 69 | 2 | IPR000727 | |
| Domain | Ig_E-set | 6.73e-03 | 104 | 69 | 3 | IPR014756 | |
| Pubmed | In search of a function for the E3B1/Abi2/Argbp1/NESH family (Review). | 7.81e-09 | 3 | 70 | 3 | 12011975 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | SRRT LARP4B ABI1 CSE1L KRT15 WARS1 SF3B6 UBR4 RGPD1 PTPN23 CNOT1 | 8.95e-08 | 665 | 70 | 11 | 30457570 |
| Pubmed | PHKB SRRT FLNA ABI1 ATP6V0D1 CSE1L DST WARS1 HSPA4L HSPH1 ERC2 ATP9A NT5DC3 NOS1 CNOT1 | 1.31e-07 | 1431 | 70 | 15 | 37142655 | |
| Pubmed | PHKB FLNA LARP4B PTPRC WARS1 PIK3R1 INPP5B HSPH1 PTPN23 CNOT1 MIER1 METTL14 MEN1 | 2.23e-07 | 1084 | 70 | 13 | 11544199 | |
| Pubmed | FLNA LARP4B ABI1 ATP6V0D1 CSE1L WARS1 MYCBP2 ABI2 UBR4 RGPD1 NT5DC3 NOS1 CNOT1 | 3.91e-07 | 1139 | 70 | 13 | 36417873 | |
| Pubmed | NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation. | 9.28e-07 | 10 | 70 | 3 | 17101133 | |
| Pubmed | 9.46e-07 | 844 | 70 | 11 | 25963833 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PHKB CPNE8 ABI2 TBK1 HSPH1 RGPD1 PTPN23 PIBF1 CFI CNOT1 MEN1 | 1.05e-06 | 853 | 70 | 11 | 28718761 |
| Pubmed | 2.01e-06 | 418 | 70 | 8 | 34709266 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16401422 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 11516653 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SRRT FLNA CPNE8 THBS1 LARP4B CSE1L KRT15 DST FAM83F HSPH1 PRSS23 METTL14 | 7.23e-06 | 1257 | 70 | 12 | 36526897 |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.11e-05 | 248 | 70 | 6 | 24006456 | |
| Pubmed | Regulation of cell-cell adhesion by Abi/Diaphanous complexes. | 1.20e-05 | 3 | 70 | 2 | 19158278 | |
| Pubmed | Biochemical characterization of copine: a ubiquitous Ca2+-dependent, phospholipid-binding protein. | 1.20e-05 | 3 | 70 | 2 | 11123945 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 37594665 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PHKB FLNA ABI1 CSE1L DST WARS1 MYCBP2 HSPA4L HSPH1 UBR4 CNOT1 | 1.77e-05 | 1149 | 70 | 11 | 35446349 |
| Pubmed | 2.23e-05 | 963 | 70 | 10 | 28671696 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 15143189 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 10995551 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 18299448 | ||
| Pubmed | The NESH/Abi-3-based WAVE2 complex is functionally distinct from the Abi-1-based WAVE2 complex. | 2.39e-05 | 4 | 70 | 2 | 26428302 | |
| Pubmed | Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization. | 2.39e-05 | 4 | 70 | 2 | 20130220 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 3.52e-05 | 621 | 70 | 8 | 22794259 | |
| Pubmed | Forced expression of NESH suppresses motility and metastatic dissemination of malignant cells. | 3.98e-05 | 5 | 70 | 2 | 11956071 | |
| Pubmed | Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1. | 3.98e-05 | 5 | 70 | 2 | 12515821 | |
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 15572692 | ||
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 21173240 | ||
| Pubmed | 4.00e-05 | 94 | 70 | 4 | 12761501 | ||
| Pubmed | SRRT LARP4B ABI1 ATP6V0D1 DST ABI2 SF3B6 HSPH1 ATP9A COMTD1 METTL14 MEN1 | 4.07e-05 | 1497 | 70 | 12 | 31527615 | |
| Pubmed | 4.60e-05 | 645 | 70 | 8 | 25281560 | ||
| Pubmed | 4.79e-05 | 322 | 70 | 6 | 26514267 | ||
| Pubmed | 5.02e-05 | 653 | 70 | 8 | 22586326 | ||
| Pubmed | 5.59e-05 | 486 | 70 | 7 | 20936779 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.60e-05 | 202 | 70 | 5 | 33005030 | |
| Pubmed | 5.96e-05 | 6 | 70 | 2 | 32209697 | ||
| Pubmed | 5.96e-05 | 6 | 70 | 2 | 27135603 | ||
| Pubmed | 6.43e-05 | 497 | 70 | 7 | 23414517 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 6.90e-05 | 344 | 70 | 6 | 30333137 | |
| Pubmed | 7.24e-05 | 347 | 70 | 6 | 17114649 | ||
| Pubmed | 7.40e-05 | 110 | 70 | 4 | 27889896 | ||
| Pubmed | 8.33e-05 | 7 | 70 | 2 | 35108541 | ||
| Pubmed | A novel HSF1-mediated death pathway that is suppressed by heat shock proteins. | 8.33e-05 | 7 | 70 | 2 | 17024176 | |
| Pubmed | 8.33e-05 | 7 | 70 | 2 | 30515151 | ||
| Pubmed | 9.32e-05 | 225 | 70 | 5 | 12168954 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 9.51e-05 | 922 | 70 | 9 | 27609421 | |
| Pubmed | 1.01e-04 | 534 | 70 | 7 | 35032548 | ||
| Pubmed | 1.11e-04 | 8 | 70 | 2 | 37871017 | ||
| Pubmed | Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase. | 1.11e-04 | 8 | 70 | 2 | 17846664 | |
| Pubmed | 1.11e-04 | 8 | 70 | 2 | 11115849 | ||
| Pubmed | 1.11e-04 | 8 | 70 | 2 | 21107423 | ||
| Pubmed | 1.12e-04 | 1168 | 70 | 10 | 19946888 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.12e-04 | 942 | 70 | 9 | 31073040 | |
| Pubmed | 1.22e-04 | 551 | 70 | 7 | 34728620 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SRRT FLNA ATP6V0D1 CSE1L WARS1 HSPA4L TBK1 HSPH1 UBR4 SPATA18 CNOT1 | 1.23e-04 | 1425 | 70 | 11 | 30948266 |
| Pubmed | FLNA KRT15 DST HSPA4L HSPH1 UBR4 RGPD1 ERC2 SPG11 STK31 MEN1 | 1.37e-04 | 1442 | 70 | 11 | 35575683 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | THBS1 WARS1 ARV1 MYCBP2 HSPA4L HSPH1 SEL1L3 LTBR PRSS23 ATP9A | 1.40e-04 | 1201 | 70 | 10 | 35696571 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 1.41e-04 | 564 | 70 | 7 | 21565611 | |
| Pubmed | 1.42e-04 | 9 | 70 | 2 | 9430674 | ||
| Pubmed | 1.42e-04 | 9 | 70 | 2 | 16815646 | ||
| Pubmed | Genetic modifiers of muscular dystrophy: implications for therapy. | 1.42e-04 | 9 | 70 | 2 | 16916601 | |
| Pubmed | 1.61e-04 | 253 | 70 | 5 | 29911972 | ||
| Pubmed | 1.78e-04 | 10 | 70 | 2 | 19171884 | ||
| Pubmed | Real-time resolution of point mutations that cause phenovariance in mice. | 1.78e-04 | 10 | 70 | 2 | 25605905 | |
| Pubmed | 1.78e-04 | 10 | 70 | 2 | 21768215 | ||
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 1.98e-04 | 142 | 70 | 4 | 11812828 | |
| Pubmed | 2.01e-04 | 56 | 70 | 3 | 27103069 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 2.09e-04 | 1024 | 70 | 9 | 24711643 | |
| Pubmed | 2.14e-04 | 604 | 70 | 7 | 38803224 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 2.15e-04 | 807 | 70 | 8 | 30575818 | |
| Pubmed | 2.17e-04 | 11 | 70 | 2 | 20598684 | ||
| Pubmed | 2.17e-04 | 11 | 70 | 2 | 21705651 | ||
| Pubmed | 2.32e-04 | 148 | 70 | 4 | 35676246 | ||
| Pubmed | 2.33e-04 | 274 | 70 | 5 | 34244482 | ||
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 2.34e-04 | 59 | 70 | 3 | 16083285 | |
| Pubmed | 2.49e-04 | 1049 | 70 | 9 | 27880917 | ||
| Pubmed | Respiratory distress and early neonatal lethality in Hspa4l/Hspa4 double-mutant mice. | 2.60e-04 | 12 | 70 | 2 | 23980576 | |
| Pubmed | Heat-shock protein HSPA4 is required for progression of spermatogenesis. | 2.60e-04 | 12 | 70 | 2 | 21487003 | |
| Pubmed | 2.61e-04 | 1297 | 70 | 10 | 33545068 | ||
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 2.62e-04 | 281 | 70 | 5 | 30455355 | |
| Pubmed | 2.79e-04 | 285 | 70 | 5 | 32838362 | ||
| Pubmed | 2.84e-04 | 156 | 70 | 4 | 22008794 | ||
| Pubmed | 2.98e-04 | 638 | 70 | 7 | 33239621 | ||
| Pubmed | K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains. | 3.12e-04 | 65 | 70 | 3 | 29378950 | |
| Pubmed | 3.58e-04 | 14 | 70 | 2 | 19380791 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 3.64e-04 | 1353 | 70 | 10 | 29467282 | |
| Pubmed | 3.84e-04 | 169 | 70 | 4 | 31462741 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 3.94e-04 | 475 | 70 | 6 | 31040226 | |
| Pubmed | HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45. | 4.71e-04 | 16 | 70 | 2 | 16524887 | |
| Pubmed | Accessory protein-like is essential for IL-18-mediated signaling. | 4.71e-04 | 16 | 70 | 2 | 15843532 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 5.06e-04 | 697 | 70 | 7 | 28298427 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 5.08e-04 | 182 | 70 | 4 | 31067453 | |
| Pubmed | 5.08e-04 | 182 | 70 | 4 | 15102471 | ||
| Pubmed | 5.33e-04 | 17 | 70 | 2 | 28634350 | ||
| Pubmed | 5.33e-04 | 17 | 70 | 2 | 24129162 | ||
| Pubmed | 5.59e-04 | 1429 | 70 | 10 | 35140242 | ||
| Pubmed | FLNA CPNE8 LARP4B ATP6V0D1 CSE1L DST HSPA4L HSPH1 UBR4 CNOT1 | 5.93e-04 | 1440 | 70 | 10 | 30833792 | |
| Pubmed | 5.98e-04 | 18 | 70 | 2 | 36877072 | ||
| Pubmed | Fate mapping and scRNA sequencing reveal origin and diversity of lymph node stromal precursors. | 5.98e-04 | 18 | 70 | 2 | 35358427 | |
| Pubmed | Lymphatic Endothelial Cells Control Initiation of Lymph Node Organogenesis. | 5.98e-04 | 18 | 70 | 2 | 28709801 | |
| Interaction | DTNB interactions | 1.38e-06 | 101 | 70 | 6 | int:DTNB | |
| Interaction | NCKAP1 interactions | 1.06e-05 | 218 | 70 | 7 | int:NCKAP1 | |
| Interaction | MCM2 interactions | SRRT FLNA MYO3A CPNE8 CPNE9 CSE1L DST TBK1 HSPH1 UBR4 RGPD1 PYGM CNOT1 MEN1 | 1.73e-05 | 1081 | 70 | 14 | int:MCM2 |
| Interaction | ITGB3 interactions | 2.77e-05 | 170 | 70 | 6 | int:ITGB3 | |
| Interaction | IQCB1 interactions | 4.19e-05 | 370 | 70 | 8 | int:IQCB1 | |
| Interaction | ATXN1 interactions | SRRT LARP4B ABI1 ATP6V0D1 CSE1L KRT15 WARS1 SF3B6 UBR4 PTPN23 STK31 CNOT1 CCDC136 | 5.17e-05 | 1039 | 70 | 13 | int:ATXN1 |
| GeneFamily | Copines | 1.70e-04 | 9 | 40 | 2 | 829 | |
| GeneFamily | Heat shock 70kDa proteins | 6.36e-04 | 17 | 40 | 2 | 583 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 4.55e-07 | 184 | 70 | 6 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-07 | 194 | 70 | 6 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-07 | 194 | 70 | 6 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 6.58e-07 | 196 | 70 | 6 | f23c33ad10f933250be98e8389a9aa278e876f96 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.78e-07 | 197 | 70 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.41e-06 | 171 | 70 | 5 | 3112d15f2a28cf4a71992db4971d960716dc1264 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.52e-06 | 176 | 70 | 5 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.76e-06 | 177 | 70 | 5 | 84930899eb2978598bc8a351cbcd9e714e46799d | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.51e-06 | 180 | 70 | 5 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-05 | 182 | 70 | 5 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-05 | 182 | 70 | 5 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.17e-05 | 188 | 70 | 5 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.36e-05 | 194 | 70 | 5 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 194 | 70 | 5 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 194 | 70 | 5 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | facs-Thymus-Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 194 | 70 | 5 | 255d6eead8da740a942a5e7d554dbd895d736d1a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 195 | 70 | 5 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | T/NK_cells-CD8+_Naive_T_cell|World / Lineage and Cell class | 1.40e-05 | 195 | 70 | 5 | 43f11068beea076e9caeb1572215c3f65c9308e1 | |
| ToppCell | facs-Thymus-Epithelium-24m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 195 | 70 | 5 | cc89261bb091ef978bd73cffc68ccdd00a8786d1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 195 | 70 | 5 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.40e-05 | 195 | 70 | 5 | bff726515ea9ce82c223e6c805000afe2e9b7206 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 195 | 70 | 5 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 1.40e-05 | 195 | 70 | 5 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 196 | 70 | 5 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.43e-05 | 196 | 70 | 5 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 196 | 70 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-05 | 196 | 70 | 5 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 196 | 70 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.43e-05 | 196 | 70 | 5 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-05 | 196 | 70 | 5 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue | 1.43e-05 | 196 | 70 | 5 | 2bf0f36af1d0934c03999dbbff3c51ae9432386d | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.47e-05 | 197 | 70 | 5 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-E|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.47e-05 | 197 | 70 | 5 | 9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.47e-05 | 197 | 70 | 5 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.47e-05 | 197 | 70 | 5 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue | 1.47e-05 | 197 | 70 | 5 | 13e6611cde9364f0c1bf681b0b26c4d2725e5f4a | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.47e-05 | 197 | 70 | 5 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.54e-05 | 199 | 70 | 5 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | COVID-19_Moderate-CD8+_Tem|COVID-19_Moderate / disease group, cell group and cell class | 1.54e-05 | 199 | 70 | 5 | adcaf9bd73933259dcf7983ca369a98e2f312d0b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.54e-05 | 199 | 70 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.54e-05 | 199 | 70 | 5 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | severe-gd_T|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.54e-05 | 199 | 70 | 5 | e5a17a9f8f3be05d6abe1116607d17633df3c7ef | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.54e-05 | 199 | 70 | 5 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | COVID-19_Moderate-CD4+_CTL|COVID-19_Moderate / disease group, cell group and cell class | 1.58e-05 | 200 | 70 | 5 | a9c73559e2c9fda1b065bfb5ce84978995505924 | |
| ToppCell | severe-CD8+_Tem|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.58e-05 | 200 | 70 | 5 | aaa2cd326dc15dee2fd975ca133359c5826f6a75 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.58e-05 | 200 | 70 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.58e-05 | 200 | 70 | 5 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.58e-05 | 200 | 70 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.58e-05 | 200 | 70 | 5 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Interneuron|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 4.66e-05 | 126 | 70 | 4 | ec445ec097c9c45cd47b8cfa8c140df5b298695e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-04 | 156 | 70 | 4 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-04 | 157 | 70 | 4 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-04 | 159 | 70 | 4 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-04 | 160 | 70 | 4 | 955acb023ce4ccfac5073c9d693db87db3856187 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 161 | 70 | 4 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 162 | 70 | 4 | 7e6d20704d77b28512690f882f9ddbbd9c5c3228 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 162 | 70 | 4 | 2c193f766f2cefe67682f34325d1de6aed778f49 | |
| ToppCell | tumor_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.29e-04 | 164 | 70 | 4 | 60fe6bb86afaebd92590135f08f5434ce0d8d73c | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-04 | 166 | 70 | 4 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-04 | 171 | 70 | 4 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-04 | 171 | 70 | 4 | fd01076574dcc82bfd4a1538812500543b16794f | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.55e-04 | 172 | 70 | 4 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-04 | 172 | 70 | 4 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.59e-04 | 173 | 70 | 4 | 1e8a43ff32eab95857c794e0bf4f0b0dba155b4a | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | 5b00a795a9dd1a77305fcac5017cb276afdc1a27 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | 3340b44c77f55244e3c2e2ea479d42563f937040 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-04 | 175 | 70 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 175 | 70 | 4 | 7de1023161233b64f11e130881c742f4cf2bff65 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.66e-04 | 175 | 70 | 4 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class | 1.73e-04 | 177 | 70 | 4 | 34e9455790bae905dd91923792f4109d18b7686e | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_C|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 178 | 70 | 4 | 7203149864cc8d5ae25329fdbf15c6b73c3d3595 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 178 | 70 | 4 | 6bef4ef48f649c6e38ae732bc08e6d7814db588b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 178 | 70 | 4 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 178 | 70 | 4 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-04 | 178 | 70 | 4 | 28bb1e3e447261d0cb47e2b6343b17b2d74db525 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.81e-04 | 179 | 70 | 4 | ac0c257e63a5994282d8b350c1b517cc3fbee52a | |
| ToppCell | ASK428-Immune-NK_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.85e-04 | 180 | 70 | 4 | 857d09446e3e6737e83d0f10bfda2ba282d5ba75 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.85e-04 | 180 | 70 | 4 | ddbab26b05f057bd78b78773381cd447bd2e2726 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 1.89e-04 | 181 | 70 | 4 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 182 | 70 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-04 | 182 | 70 | 4 | 52baef8173df0a55307c375674a37c2488066738 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.93e-04 | 182 | 70 | 4 | 345d0f9d5ee30434bc2aac17608ccdc9e61c8fa3 | |
| ToppCell | FLU-Healthy-0|FLU / Virus stimulation, Condition and Cluster | 1.97e-04 | 183 | 70 | 4 | 058604ddb06b3bef131183d86b83b422dae8f6cb | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 183 | 70 | 4 | c9d9d7dd629ce6787502103b158a07e8684a66f8 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 1.97e-04 | 183 | 70 | 4 | c9e3d91f4c3395a73295b92e25608e0effb5d241 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 183 | 70 | 4 | c7ef8ee2b3fcfa69cea0fdcb2041674b832933db | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 183 | 70 | 4 | 92eee4bdd84965ae0bd1ed1c7f26a3b83ad0cdac | |
| ToppCell | FLU-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 1.97e-04 | 183 | 70 | 4 | 7a6f18246c39864479e114f698581f667fa9c600 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-04 | 184 | 70 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 184 | 70 | 4 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 184 | 70 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | 5f5df92b328be396941b5812d00454b5ff927d30 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | dc59b8dc459a3c444c9634a0d438cbef54c40036 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | 98547c1b1828b76da810ed86082182afaaacdb3f | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.05e-04 | 185 | 70 | 4 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-04 | 186 | 70 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-04 | 187 | 70 | 4 | 6cf7be5401b81a4eeb30840fb3733d61a24af539 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.14e-04 | 187 | 70 | 4 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 2.14e-04 | 187 | 70 | 4 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| Drug | phorbol acetate myristate | TXNIP IL12B ABI1 KRT15 DST PTPRC WARS1 HSPA4L PIK3R1 SCG2 TBK1 HSPH1 LTBR PFKFB1 PRSS23 NOS1 | 3.99e-06 | 1399 | 70 | 16 | CID000004792 |
| Drug | 5-amidinobenzimidazole | 7.97e-06 | 154 | 70 | 6 | CID000001800 | |
| Disease | Malignant neoplasm of breast | 1.89e-04 | 1074 | 69 | 10 | C0006142 | |
| Disease | unipolar depression, sex interaction measurement | 2.35e-04 | 51 | 69 | 3 | EFO_0003761, EFO_0008343 | |
| Disease | atypical femoral fracture, response to bisphosphonate | 5.50e-04 | 68 | 69 | 3 | EFO_0009958, EFO_0009960 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 6.33e-04 | 16 | 69 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 6.33e-04 | 16 | 69 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | myopia (is_implicated_in) | 6.33e-04 | 16 | 69 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | Glycogen storage disease | 7.16e-04 | 17 | 69 | 2 | cv:C0017919 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 8.98e-04 | 19 | 69 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | portal hypertension (implicated_via_orthology) | 8.98e-04 | 19 | 69 | 2 | DOID:10762 (implicated_via_orthology) | |
| Disease | gout | 1.17e-03 | 196 | 69 | 4 | EFO_0004274 | |
| Disease | Glycogen Storage Disease | 1.82e-03 | 27 | 69 | 2 | C0017919 | |
| Disease | vital capacity | 2.28e-03 | 1236 | 69 | 9 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDFLKRIECYEVNYQ | 191 | P16118 | |
| CQEEKIDALQLEYSY | 396 | Q7Z569 | |
| YQDFADVVCYTQKAD | 206 | P05156 | |
| DYCENNYIQATDKRK | 31 | Q8IZP0 | |
| RAVTNYVCLKDAYEE | 256 | O60706 | |
| DSYTNLERVADYCEN | 21 | Q9NYB9 | |
| LERVADYCENNYIQS | 26 | Q9NYB9 | |
| EKSQCALEEYVRSQY | 346 | P10589 | |
| ISAQVVDYYKEACRA | 206 | Q9H3S7 | |
| TVIQDYNYCREDEEI | 351 | O00255 | |
| DYCEDNYVQATDKRK | 31 | Q9P2A4 | |
| QDECKFDYVEVYETS | 351 | Q9BY79 | |
| EDVSKRYECANFGEQ | 646 | P58215 | |
| CDYRQIEITIYKDDE | 896 | Q03001 | |
| EEYYRETGITANEKC | 196 | Q9HCE5 | |
| EVFNDCKYRRSYDSD | 446 | Q8TC71 | |
| NAVEEYVYEFRDKLC | 636 | Q92598 | |
| TEADAQQAYKYLREE | 281 | Q92615 | |
| TCFKEVDAEQYYSEL | 306 | Q9P1W3 | |
| ETADVACDGYYKVQE | 81 | Q6UWM7 | |
| ANYEIVEKCYKENSD | 181 | Q8N9F7 | |
| EECYYDENVARRNLS | 351 | P24043 | |
| CDYSQYFKTIEELRD | 151 | P19012 | |
| QAEAEKQYEDSCRVY | 481 | O75110 | |
| EASYYRDECGKAQAE | 711 | O15083 | |
| EQCQTQERYSKEYIE | 496 | P27986 | |
| RGDNKEYEYSVECQE | 181 | P29460 | |
| AYRIYCEDKQTFLQD | 221 | Q9P2X3 | |
| RDYCDNSRYNILEEV | 601 | P29475 | |
| GACQEDYRQYQAKVE | 236 | Q96F15 | |
| KELYEQECNGETVVY | 86 | Q9UKL6 | |
| ECNQEAKELYRDYNH | 36 | Q9H2C2 | |
| EECYVTEIDQDKYAV | 2376 | P21333 | |
| VAVVDADKENCSAYY | 181 | Q86VU5 | |
| CNGDYDRTVKIDVYD | 211 | Q8IYJ1 | |
| EQYVLEKGVYRNCED | 1316 | Q8N1P7 | |
| EEYERRNQDYKDICS | 486 | P32019 | |
| AQYSKAAQDVDECVE | 21 | Q8IX30 | |
| CNGDYDRTIKVEVYD | 221 | Q86YQ8 | |
| YYKCNTHDEREAVIQ | 836 | Q93100 | |
| ICRYKENEKVYENDD | 196 | Q8N108 | |
| YELEENTEKAVECYR | 61 | P0DJD0 | |
| AYSYAVENAKDIIAC | 211 | P23381 | |
| AEQIKLYYERCAEVQ | 441 | Q68CR1 | |
| AIEADIEKYICYAEQ | 266 | Q86UY8 | |
| DVKDETYDLLYQQCD | 296 | O95084 | |
| YTDDEDDIYKANNIA | 226 | P13521 | |
| DDIYKANNIAYEDVV | 231 | P13521 | |
| ETDVLAYDCAAREKY | 1301 | O75592 | |
| QEIYDCVSQTEYREK | 846 | Q5T5J6 | |
| EKVTEAQAAFYYCER | 16 | Q8NEG4 | |
| DSVDETEAVKRYNDY | 161 | Q9BXP5 | |
| ENCRKTYDTTVDDNE | 756 | Q96JN2 | |
| ECRDEYKYNVEAVEL | 1716 | A5YKK6 | |
| AEYSLAQENIKTCEY | 416 | Q9BXU1 | |
| YKCRNEDAQYSFIRE | 1281 | Q96JI7 | |
| DNCQYVYNVDQRDTD | 811 | P07996 | |
| ICDNAALYAQKYDEE | 271 | P55060 | |
| ADYEDYIKCQEKVSA | 776 | P11217 | |
| ERNDAKNAVEEYVYD | 616 | O95757 | |
| YVVYEDIFDAKNACD | 61 | Q9Y3B4 | |
| YEEDRKNYSEVQIRC | 226 | Q8WXW3 | |
| TDRVDACSDQDNVYK | 1071 | Q8IZM8 | |
| YASENQTCRDQEKEY | 36 | P36941 | |
| QQCKQTSEYLRYEDT | 61 | Q9H3M7 | |
| DLYTAEQAFVRCKDY | 711 | Q9P2L0 | |
| AVCIETAKRYNLDDY | 4311 | Q5T4S7 | |
| NCDFRVKDLQYSTDY | 536 | P08575 | |
| QCFDIEEEVSKYQEY | 636 | Q9UHD2 | |
| KDYDVYSDNDICSQE | 71 | Q8N5P1 | |
| ARADDYEQVKNVADY | 256 | P61421 | |
| YQRYTEERNCEESKA | 1241 | Q8NEV4 |